GEN

Validating CRISPR Preclinical Models with Multiomics

The power of CRISPR became definitively clear when the first CRISPR-based gene therapy, Casgevy (exa-cel), won regulatory approvals for the treatment of sickle cell disease. But CRISPR’s applications ...
SiliconANGLE

MLCommons announces MedPerf, a new benchmark for validating medical AI models

The Medical Working Group of the open machine learning consortium MLCommons today announced the availability of a new and open benchmarking platform called MedPerf. MedPerf is a big deal, the group ...
SiliconANGLE

Openlayer, creator of tools for testing and verifying machine learning models, raises $4.8M

Openlayer Inc., the creator of a novel platform for testing artificial intelligence and machine learning models, said today it has closed on a $4.8 million seed funding round. The round was led by ...
ascopubs.org

Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease For prediction of deleterious TP53 mutations, ...
Risk

Validating bank risk models under trade war stress: a framework for adaptive stress testing with AI-driven calibration and cross-industry applications

The escalation of trade tensions and tariff shocks has created persistent uncertainty for financial institutions by directly impacting the integrity of traditional bank risk models. Conventional ...

WeCP, built by Abhishek Kaushik, gets acquired by Invisible to train AI models

Invisible Technologies acquires WeCP to enhance AI expertise validation. WeCP shifts focus from hiring engineers to training ...
ascopubs.org

Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma

Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in ...